Comparison of PUVA therapy and Narrow band UVB therapy in patients with vitiligo

Comparative Study Of PUVA Therapy Versus Narrow Band UVB Therapy In The Treatment Of Vitiligo - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103249

Enrollment

Registered

2026-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: PUVA therapy: Psoralen plus ultaviolet A therapy (PUVA) administered as per standard protocol in patients with vitiligo Control Intervention1: Narrow band UVB therapy: Narrow band UVB p

Eligibility

Inclusion criteria

Inclusion criteria: Patients with diagnosis of vitiligo, Patients presenting with body surface area involvement greater than 10 percent, Patients willing to provide informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with a history of photosensitivity and photo mediated disorders , Patients with a history of administration of drugs causing photosensitization, Pregnant and lactating women, Patients with a history of skin malignancy , renal and hepatic diseases, Patients not willing to provide informed written consent to participate in the study

Design outcomes

Primary

Measure	Time frame
Improvement in vitiligo assessed by change in Vitiligo Area Scoring Index (VASI)Timepoint: At baseline, 3 months,6months, 9months and 12 months	—

Secondary

Measure	Time frame
Percentage of repigmentationTimepoint: At 1month,3month,6month,9month,12months	—

Countries

India

Contacts

Public ContactDr Sakthivel Vaithiyanathan

Vinayaka Missions Medical College and Hospital karaikal

generalmedicine@vmmckkl.edu.in9842426095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026